HBK INVESTMENTS L P - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 137 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2014. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
HBK INVESTMENTS L P ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2014$316,000
-81.9%
17,870
-84.0%
0.01%
-77.8%
Q2 2013$1,748,000–112,000–0.03%–
 Download
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q2 2014
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders